More Senators accuse Marathon CEO Aronin of exploiting Duchenne MD patients as well as FDA’s orphan incentives
A group of US Senators is tightening the screws on Marathon Pharmaceuticals in the wake of the latest drug pricing scandal.
Just weeks after Marathon …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
